2,048
Views
8
CrossRef citations to date
0
Altmetric
Research Articles

Cell migration and apoptosis in human lung cancer cells by Clove (Syzygium aromaticum) dried flower buds extract

ORCID Icon, ORCID Icon & ORCID Icon
Pages 1163-1174 | Received 27 Sep 2019, Accepted 04 Nov 2019, Published online: 18 Nov 2019

References

  • Ali I, Haque A, Saleem K, et al. Curcumin-I Knoevenagel’s condensates and their Schiff’s bases as anticancer agents: synthesis, pharmacological and simulation studies. Bioorg Med Chem. 2013;21:3808–3820. doi: 10.1016/j.bmc.2013.04.018
  • Aboul-Enein HY, Ali I. Determination of tadalafil in pharmaceutical preparation by HPLC using monolithic silica column. Talanta. 2004;65:276–228. doi: 10.1016/j.talanta.2004.06.012
  • Ali I, Gaitonde VD, Aboul-Enein HY, et al. Chiral separation of β-adrenergic blockers on cellucoat column by HPLC. Talanta. 2009;78:458–463. doi: 10.1016/j.talanta.2008.11.043
  • Ali I, Saleem K, Hussain I, et al. Polysaccharides chiral stationary phases in liquid chromatography. Sep Purif Rev. 2009;38:97–147. doi: 10.1080/15422110802589916
  • Ali I, Gupta VK, Aboul-Enein HY, et al. Role of racemization in optically active drug development. Chirality. 2007;19:453–463. doi: 10.1002/chir.20397
  • Ali I, Lone MN, Al-Othman ZA, et al. Heterocyclic scaffolds: centrality in anticancer drug development. Curr Drug Target. 2015;16:711–734. doi: 10.2174/1389450116666150309115922
  • Ali I, Sanagi MM, Aboul-Enein HY. Advances in chiral separations by non-aqueous capillary electrophoresis in pharmaceutical and biomedical analysis. Electrophoresis. 2014;35:926–936. doi: 10.1002/elps.201300222
  • Ali I, Aboul-Enein HY. Impact of immobilized polysaccharide chiral stationary phases on enantiomeric separations. J Sep Sci. 2006;29:762–769. doi: 10.1002/jssc.200500372
  • Aboul-Enein HY, Ali I. A comparative study of the enantiomeric resolution of econazole, miconazole and sulconazole by HPLC on various cellulose chiral columns in normal phase mode. J Pharm Biomed Anal. 2002;27:441–446. doi: 10.1016/S0731-7085(01)00575-1
  • Ali I, Aboul-Enein HY. Enantioseparation of some clinically used drugs by HPLC using cellulose tris-(3,5-dichlorophenylcarbamate) chiral stationary phase. Biomed Chromatogr. 2003;17:113–117. doi: 10.1002/bmc.220
  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Can J Clin. 2018;68:394–424. doi: 10.3322/caac.21492
  • Alharbi OML, Basheer AA, Khattab RA, et al. Health and environmental effects of persistent organic pollutants. J Mol Liq. 2018;263:442–453. doi: 10.1016/j.molliq.2018.05.029
  • Basheer AA. Chemical chiral pollution: impact on the society and science, and need of the regulations in the 21st century. Chiralty. 2018;30:402–406. doi: 10.1002/chir.22808
  • Ali I. Nano anti-cancer drugs: pros and cons and future perspectives. Cur Can Drug Targ. 2011;11:131–134. doi: 10.2174/156800911794328457
  • Aboul-Enein HY, Ali I. Studies on the effect of alcohols on the chiral discrimination mechanisms of amylose stationary phase on the enantioseparation of nebivolol by HPLC. J Biochem Biophys Meth. 2001;48:175–188. doi: 10.1016/S0165-022X(01)00148-8
  • Aboul-Enein HY, Ali I. Optimization strategies for HPLC enantioseparation of racemic drugs using polysaccharides and macrocyclic glycopeptide antibiotic chiral stationary phases. IL Farmaco. 2002;57:513–529. doi: 10.1016/S0014-827X(02)01242-9
  • Ali I, Naim L, Ghanem A, et al. Chiral separations of piperidine-2,6-dione analogues on Chiralpak IA and Chiralpak IB columns by using HPLC. Talanta. 2006;69:1013–1017. doi: 10.1016/j.talanta.2005.12.004
  • Aboul-Enein HY, Ali I. HPLC Enantiomeric resolution of nebivolol on normal and reversed amylose based chiral phases. Pharmazie. 2001;56:214–216.
  • Ali I, Aboul-Enein HY, Ghanem A. Enantioselective toxicities and carcinogenesis. Cur Pharmaceut Anal. 2005;1:109–125. doi: 10.2174/1573412052953328
  • Al-Othman ZA, Al-Warthan A, Ali I. Advances in enantiomeric resolution on chiral monolithic phases in liquid chromatography and electrochromatography. J Sepn Sci. 2014;37:1033–1057. doi: 10.1002/jssc.201301326
  • Ali I, Saleem K, Wesselinova D, et al. Synthesis, DNA binding, hemolytic and anticancer assays of curcumin I based ligands and their ruthenium (III) complexes. Med Chem Res. 2013;22:1386–1398. doi: 10.1007/s00044-012-0133-8
  • Ali I, Rahis-ud-din, Saleem K, et al. Social aspects of cancer genesis. Can Ther. 2011;8:6–14.
  • Aboul-Enein HY, Ali I, Simons C, et al. Enantiomeric resolution of the novel aromatase inhibitors by HPLC on cellulose and amylose based reversed and chiral stationary phases. Chirality. 2000;12:727–733. doi: 10.1002/1520-636X(2000)12:10<727::AID-CHIR5>3.0.CO;2-T
  • Erenpreisa J, Cragg M. Cancer: a matter of life cycle? Cell Biol Int. 2007;31:1507–1510. doi: 10.1016/j.cellbi.2007.08.013
  • Ajani JA. Evolving chemotherapy for advanced gastric cancer. Oncologist. 2005;10:49–58. doi: 10.1634/theoncologist.10-90003-49
  • Ali I, AL-Othman ZA, Hussain A, et al. Chiral separation of β-adrenergic blockers in human plasma by SPE-HPLC. Chromatographia. 2011;73:251–256. doi: 10.1007/s10337-010-1891-4
  • Ali I, Singh P, Aboul-Enein HY, et al. Chiral analysis of ibuprofen residues in water and sediment. Anal Lett. 2009;42:1747–1760. doi: 10.1080/00032710903060768
  • Aboul-Enein HY, Ali I. A comparison of chiral resolution of econazole, miconazole and sulconazole by HPLC using normal phase amylose CSPs. Fresenius J Anal Chem. 2001;370:951–955. doi: 10.1007/s002160100884
  • Basheer AA, Ali I. Stereoselective uptake and degradation of (±)-o,p-DDD pesticide stereomers in water-sediment system. Chirality. 2018;30:1088–1095. doi: 10.1002/chir.22989
  • Ali I, Waseem A, Wani A, et al. Synthesis and synergistic antifungal activities of a pyrazoline based ligand and its Copper (II) and Nickel (II) complexes with conventional antifungals. Microb Pathogen. 2012;53:66–73. doi: 10.1016/j.micpath.2012.04.005
  • Ali I, Wani WA, Khan A, et al. Thalidomide: a banned drug resurged into future anticancer drug. Cur Drug Ther. 2012;7:13–23. doi: 10.2174/157488512800389164
  • Ali I, Wani WA, Saleem K, et al. Syntheses, DNA binding and anticancer profiles of L-Glutamic acid ligand and its copper(II) and ruthenium(III) complexes. Med Chem. 2013;9:11–21. doi: 10.2174/157340613804488297
  • Ahmad T, Latif S, Qasmi A. Effect of 50% ethanolic extract of Syzygium aromaticum (L.) Merr. & Perry. (clove) on sexual behaviour of normal male rats. BMC Complement Altern Med. 2004;5:4–17.
  • Letelier ME, Molina-Berríos A, Cortés-Troncoso J, et al. DPPH and oxygen free radicals as pro-oxidant of biomolecules. Toxicol In Vitro. 2008;22:279–286. doi: 10.1016/j.tiv.2007.08.002
  • Boulos L. Medicinal plants of North Africa. Algonac: Reference Publications; 1983, 110.
  • Odugbemi TO. Outlines and pictures of medicinal plants from Nigeria. Lagos: University of Lagos Press; 2006.
  • Skehan P, Storeng R, Scudiero D, et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Can Inst. 1990;82:1107–1112. doi: 10.1093/jnci/82.13.1107
  • Joyeux M, Lobstein A, Anton R, et al. Comparative antilipoperoxidant, antinecrotic and scavenging properties of terpenes and biflavones from Ginkgo and some flavonoids. Plant Med. 1995;61:126–129. doi: 10.1055/s-2006-958030
  • Zheng GQ, Kenney PM, Lam LK. Sesquiterpenes from clove (Eugenia caryophyllata) as potential anticarcinogenic agents. J Nat Prod. 1992;55:999–1003. doi: 10.1021/np50085a029
  • Tanaka T, Orii Y, Nonaka G, et al. Tannins and related compounds. CXXIII. Chromone, acetophenone and phenylpropanoid glycosides and their galloyl and/or hexahydroxydiphenoyl esters from the leaves of Syzygium aromaticum MERR. Et PERRY. Chem Pharmaceut Bull. 1993;41:1232–1237. doi: 10.1248/cpb.41.1232
  • Umehara K, Takagi R, Kuroyanagi M, et al. Studies on differentiation-inducing activities of triterpenes. Chem Pharmaceut Bull. 1992;40:401–405. doi: 10.1248/cpb.40.401
  • Farag R, Badei A, El Baroty G. Influence of thyme and clove essential oils on cottonseed oil oxidation. J Am Oil Chem Soc. 1989;66:800–804. doi: 10.1007/BF02653671
  • Farag R, Badei A, Hewedi F, et al. Antioxidant activity of some spice essential oils on linoleic acid oxidation in aqueous media. J Am Oil Chem Soci. 1989;66:792–799. doi: 10.1007/BF02653670
  • Miyazawa M, Hisama M. Antimutagenic activity of phenylpropanoids from clove (Syzygium aromaticum). J Agric Food Chem. 2003;51:6413–6422. doi: 10.1021/jf030247q
  • Banerjee S, Panda CK, Das S. Clove (Syzygium aromaticum L.), a potential chemopreventive agent for lung cancer. Carcinogenesis. 2006;27:1645–1654. doi: 10.1093/carcin/bgi372
  • Liu H, Schmitz JC, Wei J, et al. Clove extract inhibits tumor growth and promotes cell cycle arrest and apoptosis. Oncol Res. 2014;21:247–259. doi: 10.3727/096504014X13946388748910
  • Schneider CA, Rasband WS, Eliceiri KW. NIH image to ImageJ: 25 years of image analysis. Nat Meth. 2012;9:671–675. doi: 10.1038/nmeth.2089
  • Collins TJ. ImageJ for microscopy. Bio Tech. July 2007;43(1 Suppl):25–30.
  • Ali I, Naqshabndi MF, Husain M. In vitro anticancer, antioxidant and DNA binding studies of Eugenia caryophyllus plant bud extracts. Paper submitted for publication, Lett. Drug Design & Discov. 2019, forthcoming.
  • Choi BY, Kim HY, Lee KH, et al. Clofilium, a potassium channel blocker, induces apoptosis of human promyelocytic leukemia (HL-60)cells via Bcl-2 insensitive activation of caspase-3. Can Lett. 1999;147:85–93. doi: 10.1016/S0304-3835(99)00280-3
  • Seo WG, Pae HO, Oh GS, et al. Ethyl acetate extract of the stem bark of Cudrania tricuspidata induces apoptosis in human leukemia HL-60 cells. Am J Chin Med. 2001;29:313–320. doi: 10.1142/S0192415X01000332
  • Pistritto G, Trisciuoglio D, Ceci C, et al. Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies. Aging (Albany NY). 2016;8:603–619. doi: 10.18632/aging.100934
  • Ameisen JC. On the origin, evolution, and nature of programmed cell death: a timeline of four billion years. Cell Death Differ. 2002;9:367–393. doi: 10.1038/sj.cdd.4400950
  • Gerl R, Vaux DL. Apoptosis in the development and treatment of cancer. Carcinogenesis. 2004;26:263–270. doi: 10.1093/carcin/bgh283
  • Elmore S. Apoptosis. A review of programmed cell death. Toxicol Pathol. 2007;35:495–516. doi: 10.1080/01926230701320337
  • Wlodkowic D, Telford W, Skommer J, et al. Apoptosis and beyond: cytometry in studies of programmed celldeath. Meth Cell Biol. 2011;103:55–98. doi: 10.1016/B978-0-12-385493-3.00004-8
  • Rice-Evans C, Miller N, Paganga G. Antioxidant properties of phenolic compounds. Trends Plant Sci. 1997;2:152–159. doi: 10.1016/S1360-1385(97)01018-2
  • Saleem A, Husheem M, Härkönen P, et al. Inhibition of cancer cell growth by crude extract and the phenolics of Terminalia chebula retz. fruit. J Ethnopharmacol. 2002;81:327–336. doi: 10.1016/S0378-8741(02)00099-5
  • Ali I, Wani WA, Saleem K, et al. Design and synthesis of thalidomide based dithiocarbamate Cu(II), Ni(II) and Ru(III) complexes as anticancer agents. Polyhedron. 2013;56:134–143. doi: 10.1016/j.poly.2013.03.056
  • Miliauskas G, Venskutonis P, Van Beek T. Screening of radical scavenging activity of some medicinal and aromatic plant extracts. Food Chem. 2004;85:231–237. doi: 10.1016/j.foodchem.2003.05.007
  • Kähkönen MP, Hopia AI, Vuorela HJ, et al. Antioxidant activity of plant extracts containing phenolic compounds. J Agric Food Chem. 1999;47:3954–3962. doi: 10.1021/jf990146l